0.269

17.11% 0.0393

Pre-market: .28 0.011 +4.09%

China Pharma Holdings Inc. (CPHI)

Overview News Price History Discussions Forecast Stock Split

China Pharma Holdings Inc. stock is traded at $0.269, with a volume of 683.60K. It is up +17.11% in the last 24 hours and up +31.22% over the past month. China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.

Previous Close:

$0.2297

Open:

$0.2212

24h Volume:

683.60K

Relative Volume:

0.64

Market Cap:

$5.18M

Revenue:

$5.54M

Net Income/Loss:

$-4.74M

P/E Ratio:

-0.8006

EPS:

-0.336

Net Cash Flow:

$-750.60K

1W Performance:

+34.43%

1M Performance:

+31.22%

6M Performance:

+15.45%

1Y Performance:

-30.12%

1-Day Range:

$0.2211

$0.2739

1-Week Range:

$0.195

$0.2739

52-Week Range:

$0.13

$0.44

China Pharma Holdings Inc. Stock (CPHI) Company Profile

Name

China Pharma Holdings Inc.

Sector

Healthcare (1172)

Industry

Drug Manufacturers - Specialty & Generic (1)

Phone

86 898 6681 1730

Address

No. 17, Jinpan Road, Second Floor, Haikou

Employee

276

Twitter

Next Earnings Date

Latest SEC Filings

CPHI's Discussions on Twitter

Compare CPHI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CPHI China Pharma Holdings Inc.	0.269	5.18M	5.54M	-4.74M	-750.60K	-0.336
ZTS Zoetis Inc	161.68	72.40B	9.26B	2.49B	2.30B	5.47
TAK Takeda Pharmaceutical Co Adr	14.93	47.12B	30.25B	1.37B	5.08B	0.4257
HLN Haleon Plc Adr	10.19	46.08B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	16.48	18.88B	16.54B	-1.64B	749.00M	-1.45
ITCI Intra Cellular Therapies Inc	131.25	13.96B	612.78M	-86.37M	-62.91M	-0.87

China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-08-10	Initiated	Rodman & Renshaw	Mkt Outperform

China Pharma Holdings Inc. Stock (CPHI) Latest News

Mar 12, 2025

Layoff Tracker: BMS’ Latest Cuts in New Jersey Will Affect 223 Employees - BioSpace

Feb 28, 2025

Feb 27, 2025

Alliance Pharma And 2 Other UK Penny Stocks With Promising Fundamentals - Yahoo Finance

Feb 27, 2025

Feb 26, 2025

Harbour Biomed newco HBM Alpha pens $395M hyperplasia drug deal - BioWorld Online

Feb 26, 2025

Mayne Pharma Group Ltd (MAYNF) (H1 2025) Earnings Call Highlights: Strong Growth in Women's ... - Yahoo Finance

Feb 26, 2025

China Pharma (NYSE:CPHI) Now Covered by StockNews.com - Defense World

Feb 26, 2025

Feb 25, 2025

Can Euro Tech's $2.2M Water Treatment Deals Signal Growth in China's Environmental Tech Market? - StockTitan

Feb 25, 2025

Feb 23, 2025

Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up – Here’s Why - Defense World

Feb 23, 2025

Feb 20, 2025

Hong Kong Pharma Digital Technology Holdings Limited Partners with Leading Chinese E-commerce Platform to Enhance Cross-Border Logistics Services - The Manila Times

Feb 20, 2025

Feb 18, 2025

VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA - PR Newswire

Feb 18, 2025

InnoCare Pharma receives approval for CLL/SLL combination therapy trial in China - Yahoo

Feb 18, 2025

China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com - Defense World

Feb 18, 2025

Feb 17, 2025

Is Pfizer Inc. (PFE) the Best Drug Stock to Buy Now? - Yahoo Finance

Feb 17, 2025

Why AbbVie Inc. (ABBV) Is One of the Best Drug Stocks to Buy Now - Yahoo Finance

Feb 17, 2025

Feb 16, 2025

U.S. investors, Big Pharma race to find new medicines in China - MSN

Feb 16, 2025

Feb 14, 2025

Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits - Quantisnow

Feb 14, 2025

CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025 - Quantisnow

Feb 14, 2025

Feb 10, 2025

Hong Kong Stock Exchange Companies List - Morningstar.com.au

Feb 10, 2025

Feb 05, 2025